GUSELKUMAB

Clinical Indication

Treating active psoriatic arthritis after inadequate response to DMARDs

Comments

In line with NICE TA711

Date of classification

September 2021

Review date

September 2021

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LMSG website list.